Recruiting HIV AIDS Studies in Houston
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
The goal of this clinical study is to learn more about the study drug lenacapavir (LEN), safety, tolerability, and pharmacokinetics (how LEN is absorbed, modified, distributed, and removed from the bo...
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
The purpose of this study is to provide data on the pharmacokinetic (PK), safety, tolerability, efficacy and acceptability of this fixed dose combination (FDC) single tablet 2-drug regimen for virolog...
About HIV AIDS Clinical Trials in Houston
HIV (human immunodeficiency virus) attacks the immune system and, if untreated, can lead to AIDS (acquired immunodeficiency syndrome). Antiretroviral therapy (ART) can control the virus and prevent transmission. Research continues to pursue a functional cure, long-acting therapies, and preventive vaccines.
There are currently 2 hiv aids clinical trials recruiting participants in Houston, TEXAS. These studies are seeking a combined 320 participants. Research is being sponsored by Gilead Sciences, ViiV Healthcare. Clinical trial participation is free and participants receive study-related medical care at no cost.
HIV AIDS Clinical Trials in Houston — FAQ
Are there hiv aids clinical trials in Houston?
Yes, there are 2 hiv aids clinical trials currently recruiting in Houston, TEXAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Houston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.
Are clinical trials in Houston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.
What hiv aids treatments are being tested?
The 2 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for hiv aids.
Data updated March 2, 2026 from ClinicalTrials.gov